Skip to main content
. 2019 Aug 31;18:165. doi: 10.1186/s12944-019-1108-2

Table 7.

Clinical Characteristics of TRIB1 rs17321515 A allele Carriers and Non-carriers in the NAFLD Patients

Parameters Carriers (n = 102) Non-carriers (n = 37) Statistics P value
Male/Female 54/48 20/17 χ2 = 0.014 0.907
Age,y 64.00 (45.00, 74.00) 67.00 (45.00, 75.50) Z = −0.851 0.395
BMI, kg/m2 26.47 (24.87, 28.74) 26.23 (24.62, 28.06) Z = −0.110 0.913
ALT, U/L 22.84 (18.27, 36.72) 22.34 (17.79, 36.40) Z = −0.434 0.665
AST, U/L 21.55 (18.84, 28.10) 21.55 (17.33, 27.56) Z = −0.591 0.555
GGT, U/L 33.15 (22.38, 47.95) 29.14 (18.47, 47.54) Z = −1.075 0.285
ALP, U/L 71.83 ± 15.31 68.47 ± 19.99 t = 1.049 0.296
TG, mmol/L 1.73 (1.16, 2.26) 1.44 (1.17, 2.17) Z = −0.624 0.532
TC, mmol/L 5.42 ± 0.80 5.53 ± 0.87 t = − 0.688 0.493
HDL, mmol/L 1.18 (1.05, 1.29) 1.21 (1.02, 1.35) Z = − 0.331 0.740
LDL, mmol/L 3.30 (2.95, 3.50) 3.40 (3.17, 3.67) Z = − 1.833 0.067
TBIL, umol/L 11.90 (9.80, 14.62) 13.90 (10.10, 17.90) Z = − 1.258 0.208
FPG, mmol/L 4.94 (4.50, 5.80) 4.96 (4.61, 5.96) Z = − 0.060 0.952
HHS Vulnerability Disclosure